Back
BioCryst Pharmaceuticals Vs. RxSight Industry Stock Comparison
Sell
35
BCRX
BioCryst Pharmaceuticals
Last Price:
8.16
Seasonality Move:
-9.69%
Sell
30
RXST
RxSight
Last Price:
53.42
Seasonality Move:
-0.72%
Sell
35
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy, Sell or Hold?
- The current BioCryst Pharmaceuticals [BCRX] share price is $7.97. The Score for BCRX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
RxSight (RXST)
is a Sell
Is RxSight a Buy, Sell or Hold?
- The current RxSight [RXST] share price is $54.16. The Score for RXST is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RXST is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCRX Stock Price Chart
What is BioCryst Pharmaceuticals's stock price today?
-
The BioCryst Pharmaceuticals share price today is $7.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing selling pressure, which indicates risk of future bearish movement.
RXST Stock Price Chart
BCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 52.47 | Buy |
| Chaikin Money Flow: | -1073813 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.73 - 8.31) | Sell |
| Bollinger Bands (100): | (5.79 - 7.89) | Buy |
RXST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 52.22 | Buy |
| Chaikin Money Flow: | -465156 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.69 - 55.69) | Sell |
| Bollinger Bands (100): | (49.39 - 59.95) | Sell |
BCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.82 | Buy |
| 20-day SMA: | 8.08 | Sell |
| 50-day SMA: | 7.71 | Buy |
| 200-day SMA: | 6.17 | Buy |
| 8-day EMA: | 7.92 | Buy |
| 20-day EMA: | 7.94 | Buy |
| 50-day EMA: | 7.62 | Buy |
| 200-day EMA: | 6.76 | Buy |
RXST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.61 | Sell |
| 20-day SMA: | 54.68 | Sell |
| 50-day SMA: | 50.69 | Buy |
| 200-day SMA: | 51.08 | Buy |
| 8-day EMA: | 54.74 | Sell |
| 20-day EMA: | 54.01 | Buy |
| 50-day EMA: | 53.07 | Buy |
| 200-day EMA: | 48.76 | Buy |
BioCryst Pharmaceuticals Earnings Growth & BCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.23 per share.
RxSight Earnings Growth & RXST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.07 per share, an increase this year of $0.85 per share, and an increase next year of $0.38 per share.
BioCryst Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
RxSight Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||